US Stock MarketDetailed Quotes

PTGX Protagonist Therapeutics

Watchlist
  • 37.590
  • +1.250+3.44%
Close Feb 28 16:00 ET
  • 37.590
  • 0.0000.00%
Post 20:01 ET
2.31BMarket Cap8.89P/E (TTM)

Protagonist Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
362.19%184.15M
-272.04%-29.18M
-4.70%-27.86M
1,123.79%268.62M
20.14%-27.43M
35.05%-70.24M
153.61%16.96M
-5.60%-26.61M
-92.43%-26.24M
8.81%-34.35M
Net income from continuing operations
448.54%275.19M
381.70%131.67M
2.62%-33.21M
20.40%-30.62M
714.80%207.34M
38.02%-78.96M
179.94%27.34M
-9.20%-34.11M
6.28%-38.46M
-61.13%-33.73M
Depreciation and amortization
-12.59%2.9M
-35.58%536K
-21.77%647K
8.65%892K
-1.44%820K
-1.69%3.31M
-0.95%832K
-3.05%827K
-2.61%821K
-0.12%832K
Other non cash items
----
----
----
----
----
--194K
--0
--0
--0
--194K
Change In working capital
-528.41%-122.61M
-918.96%-167.72M
-389.32%-2.63M
7,144.00%291.06M
-2,950.34%-243.33M
-151.24%-19.51M
-471.73%-16.46M
232.94%908K
-79.56%4.02M
66.57%-7.98M
-Change in receivables
-1,451.55%-155M
-1,550.00%-165M
10.26%43K
2,499,900.00%300M
-707,321.95%-290.04M
-335.50%-9.99M
-12,295.12%-10M
-98.52%39K
-99.95%12K
99.83%-41K
-Change in prepaid assets
-314.95%-3.77M
87.13%320K
-84.90%-1.16M
-241.15%-2.01M
-216.26%-915K
-53.30%1.75M
-94.88%171K
-194.16%-629K
192.83%1.42M
-38.47%787K
-Change in payables and accrued expense
191.63%7.82M
157.93%3.44M
52.17%3.33M
-168.55%-2.24M
140.76%3.28M
25.82%-8.53M
-5.47%-5.94M
166.05%2.19M
231.21%3.26M
-11,398.57%-8.05M
-Change in other current liabilities
18.85%-2.23M
-20.83%-841K
76.05%-166K
23.09%-523K
-3.26%-696K
-3.08%-2.74M
-3.11%-696K
-3.28%-693K
-2.87%-680K
-3.06%-674K
-Change in other working capital
--30.57M
---5.64M
---4.68M
---4.17M
--45.05M
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
362.19%184.15M
-272.04%-29.18M
-4.70%-27.86M
1,123.79%268.62M
20.14%-27.43M
35.05%-70.24M
153.61%16.96M
-5.60%-26.61M
-92.43%-26.24M
8.81%-34.35M
Investing cash flow
Cash flow from continuing investing activities
-662.86%-299.48M
85.76%-8.73M
-1,439.27%-208.71M
-442.05%-88.12M
-38.21%6.07M
-142.92%-39.26M
-1,657.48%-61.29M
-123.67%-13.56M
-25.83%25.76M
319.53%9.83M
Net PPE purchase and sale
-122.50%-1.36M
-1,531.58%-310K
-91.83%-775K
84.09%-28K
-2,320.00%-242K
23.40%-609K
72.86%-19K
-149.38%-404K
39.31%-176K
96.34%-10K
Net investment purchase and sale
-671.37%-298.13M
86.27%-8.42M
-1,480.65%-207.94M
-439.62%-88.09M
-35.82%6.31M
-141.89%-38.65M
-1,629.79%-61.27M
-122.90%-13.16M
-25.94%25.94M
334.02%9.84M
Cash from discontinued investing activities
Investing cash flow
-662.86%-299.48M
85.76%-8.73M
-1,439.27%-208.71M
-442.05%-88.12M
-38.21%6.07M
-142.92%-39.26M
-1,657.48%-61.29M
-123.67%-13.56M
-25.83%25.76M
319.53%9.83M
Financing cash flow
Cash flow from continuing financing activities
-84.83%25.85M
664.90%4.03M
-65.88%12.05M
-97.62%2.57M
-72.80%7.2M
804.96%170.48M
-4.70%527K
5,093.38%35.32M
15,807.65%108.17M
56.35%26.46M
Net common stock issuance
--0
--0
--0
--0
--0
807.72%132.1M
--8K
---78K
--107.87M
66.99%24.3M
Proceeds from stock option exercised by employees
-32.42%26.45M
676.69%4.03M
-65.95%12.05M
164.34%2.57M
244.94%7.8M
780.08%39.15M
-6.15%519K
5,089.59%35.39M
48.55%973K
-11.61%2.26M
Net other financing activities
21.98%-600K
--0
--0
--0
-500.00%-600K
-371.78%-769K
--0
--0
-2,776.00%-669K
46.24%-100K
Cash from discontinued financing activities
Financing cash flow
-84.83%25.85M
664.90%4.03M
-65.88%12.05M
-97.62%2.57M
-72.80%7.2M
804.96%170.48M
-4.70%527K
5,093.38%35.32M
15,807.65%108.17M
56.35%26.46M
Net cash flow
Beginning cash position
48.41%186.95M
-43.08%131.35M
51.04%355.87M
35.09%172.79M
48.41%186.95M
1.68%125.97M
50.78%230.75M
95.59%235.61M
29.59%127.91M
1.68%125.97M
Current changes in cash
-246.73%-89.48M
22.67%-33.87M
-4,524.55%-224.52M
69.99%183.08M
-829.09%-14.16M
2,711.57%60.98M
-61.34%-43.8M
-114.82%-4.86M
394.49%107.7M
107.70%1.94M
Effect of exchange rate changes
--0
----
----
----
----
--0
----
----
----
----
End cash Position
-47.86%97.47M
-47.86%97.47M
-43.08%131.35M
51.04%355.87M
35.09%172.79M
48.41%186.95M
48.41%186.95M
50.78%230.75M
95.59%235.61M
29.59%127.91M
Free cash flow
358.02%182.8M
-274.06%-29.49M
-6.01%-28.64M
1,116.86%268.59M
19.46%-27.67M
34.96%-70.85M
153.43%16.94M
-6.51%-27.02M
-89.69%-26.41M
9.44%-34.36M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 362.19%184.15M-272.04%-29.18M-4.70%-27.86M1,123.79%268.62M20.14%-27.43M35.05%-70.24M153.61%16.96M-5.60%-26.61M-92.43%-26.24M8.81%-34.35M
Net income from continuing operations 448.54%275.19M381.70%131.67M2.62%-33.21M20.40%-30.62M714.80%207.34M38.02%-78.96M179.94%27.34M-9.20%-34.11M6.28%-38.46M-61.13%-33.73M
Depreciation and amortization -12.59%2.9M-35.58%536K-21.77%647K8.65%892K-1.44%820K-1.69%3.31M-0.95%832K-3.05%827K-2.61%821K-0.12%832K
Other non cash items ----------------------194K--0--0--0--194K
Change In working capital -528.41%-122.61M-918.96%-167.72M-389.32%-2.63M7,144.00%291.06M-2,950.34%-243.33M-151.24%-19.51M-471.73%-16.46M232.94%908K-79.56%4.02M66.57%-7.98M
-Change in receivables -1,451.55%-155M-1,550.00%-165M10.26%43K2,499,900.00%300M-707,321.95%-290.04M-335.50%-9.99M-12,295.12%-10M-98.52%39K-99.95%12K99.83%-41K
-Change in prepaid assets -314.95%-3.77M87.13%320K-84.90%-1.16M-241.15%-2.01M-216.26%-915K-53.30%1.75M-94.88%171K-194.16%-629K192.83%1.42M-38.47%787K
-Change in payables and accrued expense 191.63%7.82M157.93%3.44M52.17%3.33M-168.55%-2.24M140.76%3.28M25.82%-8.53M-5.47%-5.94M166.05%2.19M231.21%3.26M-11,398.57%-8.05M
-Change in other current liabilities 18.85%-2.23M-20.83%-841K76.05%-166K23.09%-523K-3.26%-696K-3.08%-2.74M-3.11%-696K-3.28%-693K-2.87%-680K-3.06%-674K
-Change in other working capital --30.57M---5.64M---4.68M---4.17M--45.05M--------------------
Cash from discontinued investing activities
Operating cash flow 362.19%184.15M-272.04%-29.18M-4.70%-27.86M1,123.79%268.62M20.14%-27.43M35.05%-70.24M153.61%16.96M-5.60%-26.61M-92.43%-26.24M8.81%-34.35M
Investing cash flow
Cash flow from continuing investing activities -662.86%-299.48M85.76%-8.73M-1,439.27%-208.71M-442.05%-88.12M-38.21%6.07M-142.92%-39.26M-1,657.48%-61.29M-123.67%-13.56M-25.83%25.76M319.53%9.83M
Net PPE purchase and sale -122.50%-1.36M-1,531.58%-310K-91.83%-775K84.09%-28K-2,320.00%-242K23.40%-609K72.86%-19K-149.38%-404K39.31%-176K96.34%-10K
Net investment purchase and sale -671.37%-298.13M86.27%-8.42M-1,480.65%-207.94M-439.62%-88.09M-35.82%6.31M-141.89%-38.65M-1,629.79%-61.27M-122.90%-13.16M-25.94%25.94M334.02%9.84M
Cash from discontinued investing activities
Investing cash flow -662.86%-299.48M85.76%-8.73M-1,439.27%-208.71M-442.05%-88.12M-38.21%6.07M-142.92%-39.26M-1,657.48%-61.29M-123.67%-13.56M-25.83%25.76M319.53%9.83M
Financing cash flow
Cash flow from continuing financing activities -84.83%25.85M664.90%4.03M-65.88%12.05M-97.62%2.57M-72.80%7.2M804.96%170.48M-4.70%527K5,093.38%35.32M15,807.65%108.17M56.35%26.46M
Net common stock issuance --0--0--0--0--0807.72%132.1M--8K---78K--107.87M66.99%24.3M
Proceeds from stock option exercised by employees -32.42%26.45M676.69%4.03M-65.95%12.05M164.34%2.57M244.94%7.8M780.08%39.15M-6.15%519K5,089.59%35.39M48.55%973K-11.61%2.26M
Net other financing activities 21.98%-600K--0--0--0-500.00%-600K-371.78%-769K--0--0-2,776.00%-669K46.24%-100K
Cash from discontinued financing activities
Financing cash flow -84.83%25.85M664.90%4.03M-65.88%12.05M-97.62%2.57M-72.80%7.2M804.96%170.48M-4.70%527K5,093.38%35.32M15,807.65%108.17M56.35%26.46M
Net cash flow
Beginning cash position 48.41%186.95M-43.08%131.35M51.04%355.87M35.09%172.79M48.41%186.95M1.68%125.97M50.78%230.75M95.59%235.61M29.59%127.91M1.68%125.97M
Current changes in cash -246.73%-89.48M22.67%-33.87M-4,524.55%-224.52M69.99%183.08M-829.09%-14.16M2,711.57%60.98M-61.34%-43.8M-114.82%-4.86M394.49%107.7M107.70%1.94M
Effect of exchange rate changes --0------------------0----------------
End cash Position -47.86%97.47M-47.86%97.47M-43.08%131.35M51.04%355.87M35.09%172.79M48.41%186.95M48.41%186.95M50.78%230.75M95.59%235.61M29.59%127.91M
Free cash flow 358.02%182.8M-274.06%-29.49M-6.01%-28.64M1,116.86%268.59M19.46%-27.67M34.96%-70.85M153.43%16.94M-6.51%-27.02M-89.69%-26.41M9.44%-34.36M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Trending Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
NVIDIA
NVDA
+3.97%
Tesla
TSLA
+3.91%
Intel
INTC
+2.77%
Disney
DIS
+2.24%
Micron Technology
MU
+1.97%

Unlock the Full List